Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. OCX.NASDAQ

OncoCyte Corp (OCX NASDAQ) stock market data APIs

$3.32 -0.03(-0.9%) as of July 26, 2024
Price chart is built with Anychart

OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

OncoCyte Corp Financial Data Overview

3.345
3.32
-
3.415
3.32
2.08-4.34
44 638 K
13 365 K
1 382 K
-2.12
0.981
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'OCX',
Type: 'Common Stock',
Name: 'OncoCyte Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG008P5VFV1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1642380',
EmployerIdNumber: '27-1041563',
FiscalYearEnd: 'December',
IPODate: '2016-01-04',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: 'Domestic Primary',
IsDelisted: false,
}

OncoCyte Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 382 K
  • EBITDA -20 287 000
  • Earnings Per Share -5.32
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get OncoCyte Corp Earnings via APIs

  • Latest Release 2024-04-12
  • EPS/Forecast -1.14

Get OncoCyte Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get OncoCyte Corp latest news via APIs

Oncocyte Appoints Andrea James as Chief Financial Officer

OncoCyte Corporation IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance execu...

Oncocyte Reports Third Quarter 2023 Financial Results

-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq:...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:OCX
  • ONCOCYTE CORPORATION
Do you have any questions?
support@eodhistoricaldata.com